| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 3670 |
| 1 | DENOSUMAB | 2704 |
| 2 | AMBRISENTAN | 2521 |
| 3 | TADALAFIL | 2462 |
| 4 | SELEXIPAG | 2455 |
| 5 | MACITENTAN | 2238 |
| 6 | SILDENAFIL CITRATE | 2212 |
| 7 | EPOPROSTENOL | 1859 |
| 8 | ERGOCALCIFEROL | 1540 |
| 9 | SILDENAFIL | 1488 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 1859 | 0.1419 |
| 1 | SELEXIPAG | 2455 | 0.0941 |
| 2 | ERGOCALCIFEROL | 1540 | 0.0518 |
| 3 | PENICILLIN G POTASSIUM | 31 | 0.0426 |
| 4 | PSYLLIUM HUSK | 46 | 0.0340 |
| 5 | PAMIDRONATE DISODIUM | 115 | 0.0338 |
| 6 | RIOCIGUAT | 1092 | 0.0332 |
| 7 | SOTATERCEPT-CSRK | 200 | 0.0323 |
| 8 | MACITENTAN | 2238 | 0.0321 |
| 9 | INFLIXIMAB-DYYB | 100 | 0.0290 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 5167 |
| 1 | Endothelin Receptor Antagonist [EPC] | 4679 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 3119 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3018 |
| 4 | RANK Ligand Inhibitor [EPC] | 2705 |
| 5 | Corticosteroid [EPC] | 2612 |
| 6 | Prostacyclin Receptor Agonist [EPC] | 2455 |
| 7 | Loop Diuretic [EPC] | 1836 |
| 8 | Provitamin D2 Compound [EPC] | 1540 |
| 9 | Benzodiazepine [EPC] | 1477 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacyclin Receptor Agonist [EPC] | 2455 | 0.0941 |
| 1 | Provitamin D2 Compound [EPC] | 1540 | 0.0518 |
| 2 | Prostacycline Vasodilator [EPC] | 5167 | 0.0375 |
| 3 | Interleukin-5 Antagonist [EPC] | 25 | 0.0363 |
| 4 | Soluble Guanylate Cyclase Stimulator [EPC] | 1092 | 0.0322 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 51 | 0.0246 |
| 6 | Endothelin Receptor Antagonist [EPC] | 4679 | 0.0234 |
| 7 | Phosphodiesterase 5 Inhibitor [EPC] | 3119 | 0.0230 |
| 8 | Antithrombin-directed RNA Interaction [EPC] | 1 | 0.0179 |
| 9 | Cytolytic Agent [EPC] | 35 | 0.0150 |